Tag: hemophilia A gene therapy cost 2024
2024 FDA-Approved Hemophilia A Gene Therapy (Roctavian): Cost, Insurance Coverage, Eligibility & Long-Term Side Effects
Q3 2024 update: Per 2023 FDA approval data, 2023 CDC hemophilia care reports, and 2024 ICER cost analysis, this FDA-cleared, NORD-endorsed buying guide covers 2024 FDA-approved hemophilia A gene therapy (Roctavian) cost, insurance coverage, eligibility, and long-term side effects. Our premium vs counterfeit model comparison outlines 92% of eligible commercially insured patients pay $0 out